Detail of the clinical trial

Title of the trial A Randomized, Open Label Phase 3 Study Evaluating Safety and Efficacy of Venetoclax in combination with Azacitidine after allogeneic Stem Cell Transplantation in Subjects with Acute Myeloid Leukemia (AML) (VIALE-T)
EudraCT number 2019-002621-30
Protocol number M19-063
Sponsor AbbVie Deutschland GmbH & Co. KG, Knollstrasse, Ludwigshafen 67061, Germany
Indications Hemato-oncology
Diagnosis Acute Myeloid Leukemia (AML)
Population in clinical trial Adolescents (12-17 years)
Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2019
Date of approval by Institute (SÚKL) 24.1.2020
Date of approval by EC
Date of initiation CT in ČR
Date of ending CT in ČR
Sites Ústav hematologie a krevní transfúze,,U nemocnice 2094/1,Praha 2,128 20
FN Hradec Králové,IV. Interní a hematologická klinika,Sokolovská 581,Hradec Králové,500 05
FN Brno,Interní hematologická a onkologická klinika,Jihlavská 20,Brno ,625 00

‹‹ Back to list